OKUR compared with QTTB: revenue, margins and what each company keeps, and the suppliers and customers both name

OKUROnKure Therapeutics, Inc.

Mkt capRevenueRevenue

QTTBQ32 Bio Inc.

Mkt capRevenueRevenue

Compare

OKUROnKure Therapeutics, Inc.

QTTBQ32 Bio Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only OKUR 2

—PharmaBlock Sciences (Nanjing)unlistedsupplier

—STA Pharmaceutical Hong Kongunlistedsupplier

Shared 0

No shared counterparties.

Only QTTB 6

BMYBristol-Myers Squibb Company ("BMS")supplier

AKBAAkebia Therapeutics, Inc. ("Akebia")customer

—The Regents of the University of Colorado ("Colorado")unlistedsupplier

—

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Horizon Therapeutics Ireland DAC

unlistedsupplier

2 more · QTTB chain ›

OKUROnKure Therapeutics, Inc.

2.47▼−2.19%

Mkt cap$104.9MRevenue—

QTTBQ32 Bio Inc.

9.14▲+3.29%

Regular sessionNov 6 '26

Mkt cap$264.8MRevenue$54MQ4 FY25

Compare

Regular sessionNov 6 '26

OKUROnKure Therapeutics, Inc.

QTTBQ32 Bio Inc.

2.47▼−2.19%

Price

9.14▲+3.29%

$104.9M

Mkt cap

$264.8M

—

Revenue

$54MQ4 FY25

OKUR2.47▼−2.19%vsQTTB9.14▲+3.29%Regular sessionNov 6 '26